OTCMKTS:RCAR - RenovaCare Stock Price, News & Analysis

-0.01 (-0.68 %)
(As of 08/23/2019 10:35 AM ET)
Today's Range
Now: $1.45
50-Day Range
MA: $1.35
52-Week Range
Now: $1.45
Volume8,203 shs
Average Volume32,470 shs
Market Capitalization$126.41 million
P/E RatioN/A
Dividend YieldN/A
RenovaCare, Inc., a development-stage company, focuses on the acquisition, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System for spraying a patient's own skin stem cells onto burns and wounds for self-healing; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolOTCMKTS:RCAR



Sales & Book Value

Annual SalesN/A
Book Value$0.16 per share


Net Income$-2,120,000.00


Market Cap$126.41 million
Next Earnings Date11/18/2019 (Estimated)
OptionableNot Optionable

Receive RCAR News and Ratings via Email

Sign-up to receive the latest news and ratings for RCAR and its competitors with MarketBeat's FREE daily newsletter.

RenovaCare (OTCMKTS:RCAR) Frequently Asked Questions

What is RenovaCare's stock symbol?

RenovaCare trades on the OTCMKTS under the ticker symbol "RCAR."

How were RenovaCare's earnings last quarter?

RenovaCare Inc (OTCMKTS:RCAR) released its quarterly earnings data on Wednesday, July, 31st. The biotechnology company reported ($0.01) earnings per share for the quarter. View RenovaCare's Earnings History.

When is RenovaCare's next earnings date?

RenovaCare is scheduled to release their next quarterly earnings announcement on Monday, November 18th 2019. View Earnings Estimates for RenovaCare.

Has RenovaCare been receiving favorable news coverage?

News stories about RCAR stock have been trending positive on Friday, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. RenovaCare earned a media sentiment score of 2.5 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the company's share price in the near future. View News Stories for RenovaCare.

Who are some of RenovaCare's key competitors?

What other stocks do shareholders of RenovaCare own?

Who are RenovaCare's key executives?

RenovaCare's management team includes the folowing people:
  • Ms. Patsy J. Trisler, VP of Regulatory & Clinical Affairs (Age 71)
  • Mr. Harmel S. Rayat, Founder, Chairman & CEO (Age 58)
  • Mr. Steve Yan-Klassen, Chief Financial Officer
  • Mr. Jatinder Singh Bhogal, Chief Operating Officer (Age 52)
  • Mr. Andrew Danielson, Director of Operations

How do I buy shares of RenovaCare?

Shares of RCAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is RenovaCare's stock price today?

One share of RCAR stock can currently be purchased for approximately $1.45.

How big of a company is RenovaCare?

RenovaCare has a market capitalization of $126.41 million. RenovaCare employs 1 workers across the globe.View Additional Information About RenovaCare.

What is RenovaCare's official website?

The official website for RenovaCare is http://www.renovacareinc.com/.

How can I contact RenovaCare?

RenovaCare's mailing address is 9375 E. SHEA BLVD. SUITE 107-A, SCOTTSDALE AZ, 85260. The biotechnology company can be reached via phone at 888-398-0202.

MarketBeat Community Rating for RenovaCare (OTCMKTS RCAR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  66 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  127
MarketBeat's community ratings are surveys of what our community members think about RenovaCare and other stocks. Vote "Outperform" if you believe RCAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel